Filter Results:
(85)
Show Results For
- All HBS Web (169)
- Faculty Publications (48)
Show Results For
- All HBS Web (169)
- Faculty Publications (48)
Sort by
- September 2014
- Article
Pollution and Skin: From Epidemiological and Mechanistic Studies to Clinical Implications
By: Jean Krutmann, Wei Liu, Li Li, Xiaochuan Pan, Martha Crawford, Gabrielle Sore and Sophie Seite
In recent years, the health effects associated with air pollution have been intensively studied. Most studies focus on air pollution effects on the lung and the cardiovascular system. More recently, however, epidemiological and mechanistic studies suggest that air... View Details
Krutmann, Jean, Wei Liu, Li Li, Xiaochuan Pan, Martha Crawford, Gabrielle Sore, and Sophie Seite. "Pollution and Skin: From Epidemiological and Mechanistic Studies to Clinical Implications." Journal of Dermatological Science 76, no. 3 (September 2014): 163–168.
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details
Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- 31 Jul 2019
- Research & Ideas
Distressed Employees? Try Resilience Training
technology helps users combat mental health disorders by relaxing, meditating, and completing other mind-calming exercises. Competitors include meQuilibrium, Headspace, Big Health, and myStrength. The research team conducted an eight-week... View Details
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
is seductive, and they are actually practicing medicine by micromanaging the payment system. I tell the story in the book about how Congress motivated clinics and doctors with its payment formulas to use more of the antianemia View Details
- 18 Sep 2017
- Research & Ideas
'Likes' Lead to Nothing—and Other Hard-Learned Lessons of Social Media Marketing
at some of the social media missteps brands have taken over the past decade–and the lessons we’ve learned from them. Prioritizing technology over substance Maybe it’s because the medium seems so ephemeral, but digital brand managers are... View Details
- 2017
- Article
Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals
By: Joshua W. Buckholtz, Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan and Arielle Baskin-Sommers
Antisocial behavior is often assumed to reflect aberrant risk processing. However, many of the most significant forms of antisocial behavior, including crime, reflect the outcomes of decisions made under conditions of ambiguity rather than risk. While risk and... View Details
Keywords: Ambiguity; Neuroscience; Neuroeconomics; Choice; Psychology; Decision Choice And Uncertainty; Behavior; Decision Choices and Conditions; Cost vs Benefits; Health Disorders
Buckholtz, Joshua W., Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan, and Arielle Baskin-Sommers. "Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals." Art. 2030. Scientific Reports 7 (2017).
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 21 Apr 2021
- Research & Ideas
The Pandemic Conversations That Leaders Need to Have Now
leaders manage these conversations effectively. Drawing on our insights and those of others, we offer this guide to help leaders have the kinds of discussions we need to be having right now. The four I’s of conversational leadership The book Talk, Inc.: How Trusted... View Details
- 2009
- Working Paper
Mental Health in the Aftermath of Conflict
By: Quy-Toan Do and Lakshmi Iyer
We survey the recent literature on the mental health effects of conflict. We highlight the methodological challenges faced in this literature, which include the lack of validated mental health scales in a survey context, the difficulties in measuring individual... View Details
Keywords: Ethnicity; War; Health Disorders; Policy; Health Care and Treatment; Conflict and Resolution; Bosnia and Hercegovina
Do, Quy-Toan, and Lakshmi Iyer. "Mental Health in the Aftermath of Conflict." Harvard Business School Working Paper, No. 10-040, November 2009.
- 2012
- Chapter
Mental Health in the Aftermath of Conflict
By: Quy-Toan Do and Lakshmi Iyer
We survey the recent literature on the mental health effects of conflict. We highlight the methodological challenges faced in this literature, which include the lack of validated mental health scales in a survey context, the difficulties in measuring individual... View Details
Keywords: Conflict of Interests; Measurement and Metrics; Surveys; Analytics and Data Science; Ethnicity; War; Health Disorders; Body of Literature; Problems and Challenges; Bosnia and Hercegovina
Do, Quy-Toan, and Lakshmi Iyer. "Mental Health in the Aftermath of Conflict." In Oxford Handbook of the Economics of Peace and Conflict, edited by Michelle Garfinkel and Stergios Skaperdas. Oxford University Press, 2012.
- 06 Feb 2013
- What Do You Think?
Is ‘Conscious Capitalism’ an Antidote to Income Inequality?
never mind narcissism and all the disorders of greed We can't fix the world with economic systems too big a job all we tiny ones have is our love and conscience." Etienne Douaze maintains that the concept is alive and well in Germany's... View Details
Keywords: by James Heskett
- June 2013
- Article
Unconscious Thought Reduces Intrusion Development: A Replication and Extension
By: Julie Krans, Dorte Janecko and Maarten W. Bos
Background and Objectives: Intrusive images after a traumatic event, a hallmark feature of post-traumatic stress disorder, are suggested to develop because the trauma memory is disorganized and not integrated into autobiographical memory. Unconscious Thought... View Details
Krans, Julie, Dorte Janecko, and Maarten W. Bos. "Unconscious Thought Reduces Intrusion Development: A Replication and Extension." Journal of Behavior Therapy and Experimental Psychiatry 44, no. 2 (June 2013): 179–185.
- 2009
- Working Paper
Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
By: Arthur Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Health Testing and Trials; Power and Influence; Competitive Strategy; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur. "Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location." Harvard Business School Working Paper, No. 09-118, April 2009.
- May 2016
- Article
Transformation of Health Care—Perspectives of Opinion Leaders
By: Joanne Disch, Thomas W. Feeley, Diana J. Mason, Richard L. Schilsky, Ellen L. Stovall and Shelley Fuld Nasso
"What Health System Transformations Do You Believe Are Necessary for the Future of Health Care?" We need to transform to a true value-based health care delivery system. That means organizing care around medical conditions, not simply around hospitals and doctors. We... View Details
- 2006
- Working Paper
Male Circumcision and AIDS: The Macroeconomic Impact of a Health Crisis
By: Amrita Ahuja, Brian Wendell and Eric D. Werker
Theories abound on the potential macroeconomic impact of AIDS in Africa, yet there have been surprisingly few empirical studies to test the mixed theoretical predictions. In this paper, we examine the impact of the AIDS epidemic on African nations through 2005 using... View Details
Keywords: Macroeconomics; Health Disorders; Welfare or Wellbeing; Poverty; Research; Education; Nutrition; Risk Management; Africa
Ahuja, Amrita, Brian Wendell, and Eric D. Werker. "Male Circumcision and AIDS: The Macroeconomic Impact of a Health Crisis." Harvard Business School Working Paper, No. 07-025, October 2006. (Revised March 2009.)
- 03 Jul 2012
- First Look
First Look: July 3
PublicationsTalk, Inc.: How Trusted Leaders Use Conversation to Power Their Organizations Authors:Boris Groysberg and Michael Slind Publication:Harvard Business Review Press, 2012 Abstract How can leaders make their big or growing... View Details
Keywords: Sean Silverthorne
- Article
Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations
By: Zoe Chance and Rohit Deshpandé
It is more than mere coincidence that the highest rates of HIV occur in the world's poorest countries. Of the over 40 million people currently living with HIV, 95 percent are in the developing world. The first part of this paper explores the economics of HIV and... View Details
Keywords: Health Disorders; Developing Countries and Economies; Poverty; Health Care and Treatment; Social Marketing; Perspective; Customer Focus and Relationships; Profit; Africa; Asia; South America
Chance, Zoe, and Rohit Deshpandé. "Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations." Special Issue on Metric and Interpretive Explorations of Macromarketing. Journal of Macromarketing 29, no. 3 (September 2009).
- 2010
- Working Paper
Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative
By: Nava Ashraf, Gunther Fink and David N. Weil
Since 2003, Zambia has been engaged in a large-scale, centrally coordinated national anti-malaria campaign which has become a model in sub-Saharan Africa. This paper aims at quantifying the individual and macro level benefits of this campaign, which involved mass... View Details
Keywords: Cost vs Benefits; Developing Countries and Economies; Health Care and Treatment; Health Disorders; Performance Evaluation; Programs; Health Industry; Zambia
Ashraf, Nava, Gunther Fink, and David N. Weil. "Evaluating the Effects of Large-Scale Health Interventions in Developing Countries: The Zambian Malaria Initiative." NBER Working Paper Series, No. 16069, June 2010.
- January 2014
- Teaching Note
Dr. Benjamin Hooks and Children's Health Forum
By: Rosabeth Moss Kanter and Ai-Ling Malone
The case includes law, business, and public health perspectives on an African American leader's social entrepreneurship and leadership in other social movements. Later in his life, Dr. Benjamin Hooks championed the eradication of lead poisoning. Prior to that Hooks... View Details
- January 2024 (Revised April 2024)
- Case
Target Malaria: Editing Mosquitoes through Gene Drives
By: Shikhar Ghosh and Shweta Bagai
Target Malaria, a non-profit research consortium, is exploring the application of CRISPR-Cas9 gene editing technology to combat malaria in Sub-Saharan Africa. Its approach uses gene drives, a revolutionary tool, to suppress the population of malaria-carrying... View Details
Keywords: Health Disorders; Technological Innovation; Nonprofit Organizations; Business Strategy; Genetics; Ethics; Governing Rules, Regulations, and Reforms; United States; United Kingdom; Burkina Faso; Africa
Ghosh, Shikhar, and Shweta Bagai. "Target Malaria: Editing Mosquitoes through Gene Drives." Harvard Business School Case 824-068, January 2024. (Revised April 2024.)